Author

Kayla Xu

Scripps Research InstitutePrimary ORCID profile (0009-0009-6493-2580 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Kayla XuiD1 paper · City Of Hope National Medical Center

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Assay:metagenomics· 1 Approach:statistical model· 1

Frequent Co-Authors

A. C. HuttenlocheriD· 1 shared Andrew B. WardiD· 1 shared Angela L. F. GibsoniD· 1 shared Braden Christenson· 1 shared Charles Daniel MuriniD· 1 shared Daniel P. LeamaniD· 1 shared Delanie Arend· 1 shared Elizabeth C. TownsendiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. C. HuttenlocherORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The membrane distal domain of CD16a allosterically regulates NK cell ADCC

Tania Cid, Monica Fernandez-Quintéro, Hijab Fatima, Ema Robinson, Braden Christenson, Johannes R. Loeffler, Daniel P. Leaman, Ryan Lin, Kayla Xu, Jessica Matthias, Scott C. Henderson, Kathryn Spencer, Joseph Jardine, Michael B. Zwick, Andrew B. Ward, , Charles Daniel Murin

This paper identifies an allosteric checkpoint in CD16a that regulates NK cell ADCC independently of IgG-Fc binding, revealing a mechanism for modulating immune responses.

bioRxiv · Jul 6, 2026 · PreprintImmunology

Still Not Sterile: Chlorhexidine gluconate treatment does not completely reduce skin microbial bioburden and promotes pathogen overabundance in patients undergoing elective surgeries.

Elizabeth C. Townsend, Kayla Xu, Karinda De La Cruz, Lynda Huang, Shelby Sandstrom, Delanie Arend, Owen Gromek, J. E. Scarborough, A. C. Huttenlocher, Angela L. F. Gibson, Lindsay Kalan

This study shows that chlorhexidine gluconate reduces viable skin microbial bioburden but does not achieve complete sterility, and temporarily increases pathogen abundance before microbiome recovery.

Microbiology Spectrum · Apr 10, 2025Peer-reviewedMicrobiology